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JAK/STATAngiotensin II (AII), the active component of the renin angiotensin system (RAS), plays a vital role in the reg-
ulation of physiological processes of the cardiovascular system, but also has autocrine and paracrine actions
in various tissues and organs. Many studies have shown the existence of RAS in the pancreas of humans and
rodents. The aim of this study was to evaluate potential signaling pathways mediated by AII in isolated pan-
creatic islets of rats. Phosphorylation of MAPKs (ERK1/2, JNK and p38MAPK), and the interaction between
proteins JAK/STAT were evaluated. AII increased JAK2/STAT1 (42%) and JAK2/STAT3 (100%) interaction with-
out altering the total content of JAK2. Analyzing the activation of MAPKs (ERK1/2, JNK and p38MAPK) in iso-
lated pancreatic islets from rats we observed that AII rapidly (3 min) promoted a signiﬁcant increase in the
phosphorylation degree of these proteins after incubation with the hormone. Curiously JNK protein phos-
phorylation was inhibited by DPI, suggesting the involvement of NAD(P)H oxidase in the activation of
protein.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
The renin–angiotensin system (RAS) plays an important role in
the regulation of local and systemic blood ﬂow and blood pressure
[1]. The RAS also has paracrine and autocrine actions in various tis-
sues and organs [2]. Angiotensin II (AII), an octapeptide hormone,
acutely regulates ions and water homeostasis and causes vasocon-
striction. Chronic stimulation by AII promotes cardiac and vascular
hypertrophy, and inﬂuences cell growth, apoptosis, migration, in-
ﬂammation and ﬁbrosis [1]. Most of the responses to AII occurs
through AT1 receptor activation (a G protein coupled receptor) that
leads to phosphorylation of several tyrosine kinases including the
Janus Kinase family (JAK)[3]. The downstream protein phosphoryla-
tions include: the signal transducers activators of transcription
(STATs), the Mitogen Activated Protein Kinases (MAPKs), Src kinases
and Focal adhesion kinase (FAK) [4,5]. In hypertension and type 2 di-
abetes (DM2), AII and oxidative stress activate JAK/STAT [6] and
MAPK [7] molecules. AII activates the JAK/STAT mainly through AT1
receptor [8–11]. The effects mediated by AII are abolished when of
the STAT1 and STAT3 proteins are inhibited [12]. The MAPKs are ser-
ine–threonine kinases that mediate intracellular signaling associateda, Universidade Federal de São
São Paulo, Brazil, 04023–062.
).
vier OA license.to a variety of cell functions including cell proliferation, differentia-
tion and also cell death [13]. The family of mammalian MAPKs com-
prises the extracellular signal regulated kinase (ERK), p38MAPK
kinase and c-Jun NH2-terminal (JNK, also known as stress-activated
protein kinase or SAPK). AII activates these proteins in several tissues
such as vascular smooth muscle. Activation of MAPKs has been asso-
ciated to hypertension, atherosclerosis and diabetes being considered
the main mechanism promoting vascular damage in these conditions.
The metabolic syndrome includes impaired in glucose metabo-
lism, insulin resistance and beta cell dysfunction. Glucotoxicity and
lipotoxicity are involved in beta cell dysfunction and seem to be asso-
ciated with increased oxidative stress [14,15]. Chronic hyperglycemia
causes glucotoxicity in INS-1E beta cells and increasing AT1 receptor
protein expression. These changes impair glucose-stimulated insulin
secretion possibly through activation of NADPH oxidase, thereby pro-
moting oxidative stress [16]. Pancreatic beta cells are potentially sus-
ceptible to oxidative stress due to low expression of antioxidant
enzymes that seem to be one of the mechanisms involved in the
beta cells mass loss in diabetes [17–19]. Recently, our group demon-
strated that AII promotes a large production of ROS, in a dose-
dependent manner, through NAD(P)H oxidase in pancreatic islets
[20]. However, the signaling pathways involved in NAD(P)H oxidase
activation are not established yet. The aim of this study was then to
investigate the AII-induced JAK/STAT and MAPK signaling in isolated
rat pancreatic islets. The involvement of ROS was assessed by using
NAD(P)H oxidase inhibitor.
2 E.S. Alves et al. / Regulatory Peptides 175 (2012) 1–62. Materials and methods
2.1. Reagents
The reagents for sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and immunoblotting were obtained
from Bio-Rad (Richmond, CA, USA). Tris, EDTA, aprotinin, PMSF,
dithiothreitol (DTT), Triton X-100, Tween 20, glycerol, angiotensin
II, diphenylene iodonium (DPI) and collagenase were purchased
from Sigma-Aldrich (St. Louis, MO, USA). The JAK2, STAT1 and
STAT3 antibodies were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). JNK, pJNK, p38MAPK, phospho-p38MAPK,
ERK1/2 and phopho-ERK1/2 antibodies were from Cell Signaling
Technology Inc. (Danvers, MA, USA). The enhanced chemilumines-
cence reagent kit, ECL, was from GE Healthcare (Buckinghamshire,
UK).
2.2. Animals
The experiments were performed following the guidelines of the
Animal Research Ethics Committee of the Federal University of Sao
Paulo — UNIFESP. The rats were kept in groups of ﬁve at 23 °C in a
room with a light/dark cycle of 12/12 h (lights on at 07:00 h). For
each experiment, 2–4 eight weeks-old female albino (150–200 g)
rats, were used as indicated in the Figure legends.
2.3. Isolation of pancreatic islets
Islets of Langerhans were isolated after collagenase digestion as
previously described [21]. Brieﬂy, rat islets were isolated by disten-
sion of the pancreas via the pancreatic duct with collagenase solution
(0.68 mg/mL). The pancreas was then removed and digested in a
shaking water bath at 37 °C.
2.4. Analysis of DNA fragmentation in isolated pancreatic islets
Groups of 20 islets were isolated as previously described and were
incubated with AII (10−8 M) in the presence and absence of DPI for
1 h at 37 °C. Following this process the samples were centrifuged for
removal of the supernatant and islets were resuspended in hypotonic
solution of propidium iodide (PI) containg 0.1% citrate sodium and
0.1% Triton X-100 following incubation for 30 min at 4 °C. Samples
were analyzed in ﬂow cytometer (FACSCalibur — Becton Dickinson,
San Juan, CA, USA). Fluorescence was determined in the range of
560–680 nm. Ten thousand events per sample were acquired in histo-
grams, and analyzed using the Cell Quest software (Becton Dickinson,
San Juan, CA, USA).
2.5. Western blotting analysis
Batches of 300 islets were incubated for 30 min at 37 °C in the
Krebs-Henseleit/KH buffer (139 mM Na+, 5 mM K+, 1 mM Ca2+,
1 mMMg2+, 124 mM Cl−, 24 mM HCO3−) in the presence or ab-
sence of AII as indicated in the ﬁgure legends. Thereafter, solubili-
zation buffer containing 100 mM Tris, pH 7.6, 1% Triton X-100,
0.01 mg/mL aprotinin, 2 mM PMSF, 10 mM Na3VO4, 10 mM NaF,
10 mM Na4P2O7, and 10 mM EDTA was added and the isolated
pancreatic islets were sonicated to disrupt the cells. Insoluble ma-
terial was removed by 30 min centrifugation at 11,000 rpm and
4 °C. The supernatant was used for immunoprecipitation with
anti-JAK2 antibody overnight. The immunocomplexes were
bound to protein A-sepharose (6 MB, GE Healthcare,) following
treatment with sample buffer containing 100 mM DTT and boiled
for 5 min. The samples were subjected to 10% SDS-PAGE in a min-
iature slab gel apparatus (Mini-Protean, Bio-Rad Laboratories Inc,
Richmond, USA). Electrotransfer of proteins from the gel tonitrocellulose membrane was performed for 90 min at 120 V (con-
stant) in a miniature transfer apparatus (Mini-Protean, Bio-Rad
Laboratories Inc, Richmond, USA). To reduce non-speciﬁc protein
binding to the nitrocellulose membrane, the ﬁlter was preincu-
bated for 2 h at room temperature in blocking buffer (5% nonfat
dry milk, 10 mM Tris, 150 mM NaCl and 0.02% Tween 20). The ni-
trocellulose membrane blots were incubated overnight at 4 °C
with the speciﬁc antibodies described in the ﬁgure legends diluted
in blocking buffer (3% nonfat dry milk, 10 mM Tris, 150 mM NaCl
and 0.02% Tween 20). After that, the membranes were incubated
with secondary antibody (1:10000) conjugated to horseradish
peroxidase and diluted in blocking buffer (1% nonfat dry milk,
10 mM Tris, 150 mM NaCl and 0.02% Tween 20) for 60 min. To vi-
sualize the autoradiography, enhanced chemiluminescence re-
agents (ECL, GE Healthcare, Buckinghamshire, UK) were used
and the membranes were exposed to preﬂashed Kodak XAR ﬁlm
(Eastman Kodak, Rochester, NY). Band intensities were quantiﬁed
by optical densitometry (Scion Image Software, Frederick, MD,
USA) of the developed autoradiographs.
For whole tissue extracts, similar sized aliquots were subjected to
SDS-PAGE and immunoblotted as previously described with the indi-
cated antibodies in the ﬁgure legends (anti-JNK, anti-phospho-JNK,
anti-p38MAPK, anti-phospho-p38MAPK, anti-ERK1/2 and anti-
phospho-ERK1/2).
2.6. Statistical analysis
Results are presented as means±SEM. Statistical analysis were
performed using the unpaired Student's t test and one way ANOVA




In order to evaluate the viability of pancreatic islets after AII
and/or DPI treatments, we performed DNA-fragmentation assays
based on PI (propidium iodide) technique as described in
Materials and methods section. Fig. 1 shows the incorporation of
PI on the DNA in cells isolated from the pancreatic islets incubated
with 2.8 mM glucose (control) or 10−8 M AII in the presence or
absence of DPI (10 μM). There were no signiﬁcant differences in
DNA integrity after incubation in the presence of AII or DPI.
3.2. JAK/STAT activation and interaction with STAT1 and STAT3 induced
by AII in isolated pancreatic islets
To assess whether AII could activate the JAK/STAT in isolated pan-
creatic islets, groups of 300 islets were incubated with AII(10−8 M)
for 60 min. After that, the islets were homogenized in speciﬁc extrac-
tion buffer and the homogenate was subjected to immunoprecipita-
tion with anti-JAK2 antibody. The immunocomplexes were
subjected to SDS-polyacrylamide gel and electrotransfered to nitroce-
lulose membranes that were incubated with anti-STAT1 and/or anti-
STAT3 antibodies. AII caused a signiﬁcant increase in the JAK2/
STAT1 association (42%) without altering the total protein content
of JAK2 (Fig. 2). Similarly, the association of JAK2/STAT3 was in-
creased by two-fold due to AII treatment when compared to the con-
trol group (glucose 2.8 mM). There was no change in the total
amount of JAK2 (Fig. 3).
3.3. Effect of AII on ERK1/2 activation in isolated pancreatic islets
AII treatment provoked a signiﬁcant increase of ERK1/2 phosphor-
ylation after three minutes of incubation, which returned to baseline
Fig. 1. Analysis of DNA fragmentation and cell death by ﬂow cytometry. Groups of 20
pancreatic islets were isolated and incubated with 2.8 mM glucose(G) or 2.8 mM glu-
cose plus AII 10−8 M (AII) in the presence or absence of DPI (10 μM). Results represent
the% of cells with DNA fragmentation. Flow cytometric analysis of DNA fragmentation
used propidium iodide staining. Results are expressed as mean±SEM of 5 independent
experiments. *pb0.05.
Fig. 2. AII-induced JAK2/STAT1 interaction in isolated pancreatic islets. Pancreatic islets
were isolated and incubated with 2.8 mM glucose (G) or 2.8 mM glucose plus and AII
10−8 M (AII). After incubation, proteins were solubilized in extraction buffer and
immunoprecipitated with anti-JAK2 antibody. The samples were then subjected to
electrophoresis on polyacrylamide gel. After transfer to nitrocellulose membrane, im-
munoblotting was performed with anti-STAT1 antibody. Results are expressed as
mean±SEM of 5 independent experiments. *pb0.05.
Fig. 3. AII-induced JAK2/STAT3 interaction in isolated pancreatic islets. Pancreatic islets
were isolated and incubated with 2.8 mM glucose (G) or 2.8 mM glucose plus and AII
10−8 M (AII). After incubation, proteins were solubilized in extraction buffer and
immunoprecipitated with anti-JAK2 antibody. The samples were then subjected to
electrophoresis on polyacrylamide gel. After transfer to nitrocellulose membrane, im-
munoblotting was performed with anti-STAT3 antibody. The results are expressed as
mean±SEM of 5 independent experiments. *pb0.05.
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phosphorylation of this kinase after stimulation with AII. The total
protein content also remained unchanged (Fig. 4).
3.4. Effect of AII on p38 MAPK activation in isolated pancreatic islets
After 3 min incubation in the presence of AII there was a signiﬁ-
cant increase in p38MAPK phosphorylation that returned to baseline
after 60 min (Fig. 5). To determine the involvement of NAD(P)Hoxidase in this effect, the samples were also incubated in the presence
of 10 μM DPI, an inhibitor of this enzyme. Incubation with DPI did not
alter the phosphorylation of p38MAPK induced by AII. There was no
difference in the total content of p38MAPK (Fig. 5).3.5. Effect of AII on JNK activation in isolated pancreatic islets
AII treatment increased the phosphorylation of this protein at
3 min incubation that also returned to baseline after 60 min (Fig. 6).
Treatment with DPI abolished the JNK phosphorylation stimulated
Fig. 4. AII-induced ERK1/2 phosphorylation in isolated pancreatic islets. Pancreatic islets
were isolated and incubated with 2.8 mM glucose (G) or 2.8 mM glucose plus and AII
10−8 M (AII) in presence or absence of DPI (10 μM). After incubation the proteins
were solubilized in extraction buffer and subjected to polyacrylamide gel electrophore-
sis. After transfer to nitrocelulose membrane, immunoblotting was performed with
anti-phopsho ERK1/2 antibody. Phosphorylation was normalized to total ERK1/2 protein
content. The results are expressed as mean±SEM of 5 independent experiments.
*pb0.05.
Fig. 6. AII-induced JNK phosphorylation in isolated pancreatic islets. Pancreatic islets
were isolated and incubated with 2.8 mM glucose (G) or 2.8 mM glucose plus and AII
10−8 M (AII) in the presence or absence of DPI (10 μM). After incubation, the proteins
were solubilized in extraction buffer and subjected to polyacrylamide gel electrophore-
sis. After transfer to nitrocellulose membrane, immunoblotting was performed with
anti-phospho JNK antibody. Phosphorylation was normalized to total JNK protein con-
tent. The results are expressed as mean±SEM of 5 independent experiments. *pb0.05.
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remained unchanged (Fig. 6).4. Discussion
Increased production of ROS is associated to several deleteri-
ous mechanisms and cell death. We have previously demonstrat-
ed that AII promotes increased superoxide production in
pancreatic islets in a dose–response manner reaching the maxi-
mum response at 10−6 M. In order to avoid deleterious effects
for the pancreatic islets in this study, AII concentration was set
at 10−8 M [20]. As indicated by DNA fragmentation assays,Fig. 5. AII-induced p38MAPK phosphorylation in isolated pancreatic islets. Pancreatic
islets were isolated and incubated with 2.8 mM glucose (G) or 2.8 mM glucose plus
and AII 10−8 M (AII) in presence or absence of DPI (10 μM). After incubation, the pro-
teins were solubilized in extraction buffer and subjected to polyacrylamide gel electro-
phoresis. After transfer to nitrocelulose membrane, immunoblotting was performed
with anti-phospho p38MAPK. Phosphorylation was normalized to total p38MAPK pro-
tein content. The results are expressed as mean±SEM of 5 independent experiments.
*pb0.05.treatment with AII and DPI did not affect pancreatic islet integrity
(Fig. 1). So, the experimental protocol used allows the evaluation
of the effect of supraphysiological doses of AII on signaling path-
ways as proposed.
AII promotes JAK/STAT activation and the recruitment of members
of MAPKs family including ERK1/2, p38MAPK and JNK [22–24]. The
stimulation of these pathways leads to cardiac hypertrophy, inﬂam-
mation and vascular smooth muscle growth, in addition to increased
oxidative stress demonstrating the potential role of AII as a pro-
inﬂammatory agent [25–27]. In our previous study, AII led to an in-
crease of superoxide radicals generation in isolated pancreatic islets
and this effect was abolished by DPI, an inhibitor of NAD(P)H oxidase
[20].
Morgan et al. [28] showed an increased expression of the com-
ponents of NAD(P)H oxidase complex and subsequent increased
production of superoxide radicals after treatment of pancreatic
cells with an pro-inﬂammatory agent, IL-1b. Thus, it is possible
that inﬂammatory stimuli such as IL-1b or AII can also activate
these pathways in pancreatic islets, thereby causing oxidative
stress. High content of ROS and oxidative stress are reported in
pancreatic beta cells from animals with DM2 that may contribute
to beta cell dysfunction [29]. Superoxide radicals can also act as
second messengers and activate other proteins linked to cell
growth, mitogenesis and inﬂammation. Similar to cytokine, AII is
able to phosphorylate JAK2 protein and to increase its association
with STAT proteins, which then migrates to the nucleus and acti-
vates gene expression. In the present study, AII was able to in-
crease JAK2 association with STAT1 (Fig. 2) and also with STAT3
proteins (Fig. 3) in pancreatic islets. In isolated rat pancreatic is-
lets, AII rapidly promotes maximum activation of NAD(P)H oxi-
dase and subsequent increase in the production of superoxide
[20] that leads to activation of MAPKs proteins [30,31]. Our results
showed that AII promotes an increase in ERK1/2, p38MAPK and
JNK phosphorylation in rat pancreatic islets from.
The ERK1/2 proteins are involved in signal transduction of several
growth factors, mitogenic factors and hormones. These proteins,
when activated by AII, may stimulate contraction of vascular smooth
muscle and increased oxidative stress. In our study, AII caused an in-
crease in ERK1/2 phosphorylation after 3 min incubation, but this ef-
fect was not abolished by DPI (Fig. 4). In aorta isolated from
5E.S. Alves et al. / Regulatory Peptides 175 (2012) 1–6hypertensive rats, AII infusion lead to an increase of ERK1/2 phosphor-
ylation and the subsequent increase in the generation of superoxide.
This effect was abolished when an inhibitor of ERK1/2 was used, but
not by apocynin or tempol treatment [32]. In the present study AII ac-
tivates ERK1/2 in isolated pancreatic islets through NAD(P)H oxidase
independent mechanism (Fig. 4).
P38MAPK and JNK are activated mainly by inﬂammatory cyto-
kines and cellular stressors agents being involved in activation of
pathways related to apoptosis and cell death. These two proteins
can also be activated by superoxide radicals derived from
NAD(P)H oxidase [33,34]. AII increased the p38MAPK phosphor-
ylation (Fig. 5) and, similarly to ERK1/2, this effect was not pre-
vented when the islets were pre-treated with DPI. On the other
hand, AII increased JNK phosphorylation and treatment with
DPI abolished this response, so NAD(P)H oxidase modulates this
effect (Fig. 6).
JNK pathway is activated by various stressor signals, such as cyto-
kines, AII and oxidative stress. The activation of JNK and oxidative
stress are probably involved in the deterioration of beta cell function
and in the DM2 genesis.
Forkhead box-containg protein O-subfamily (FOXO1) is a tran-
scription factor that plays a key role in the regulation of cell cycle
progression, determination of cell size, cell death and cell differenti-
ation, stress resistance and energy metabolism [35]. In pancreas of
adult animals, FOXO1 is exclusively expressed in pancreatic beta
cells. It is not found in acinar cells or other cell types found in pan-
creas [36]. In pancreatic islets activation of FOXO1 leads to an inhibi-
tion of the transcription factor PDX-1 (pancreatic duodenal
hemobox). PDX-1 plays an important role in the function and
growth of beta cells. After being phosphorylated, FOXO1 migrates
to the nucleus and inactivates PDX-1. Oxidative stress promotes
FOXO1 translocation from the cytoplasm to the nucleus. PDX-1 in
turn translocates from the nucleus to the cytoplasm leading to an in-
hibition of cell growth and proliferation [37,38]. After incubation
with AII, no signiﬁcant difference in FOXO1 phosphorylation was ob-
served at 3 or 60 min incubations (data not shown). However we
noticed a tendency of increase in FOXO1 phosphorylation at 3 min,
suggesting that this pathway can also be activated by AII in isolated
pancreatic islets. Our results are not in agreement with data found
for FOXO1 phosphorylation through by JNK activation.
We demonstrated herein that AII activate MAPKs via activation of
JAK/STAT in isolated rat pancreatic islets. Among the MAPKs assessed
the activation of JNK seems to involve the participation of NAD(P)H
oxidase (Fig. 7).Fig. 7. Proposed model of activation of protein JAK/STAT and MAPK by Angiotensin II in
isolated rat islets. AII binds to the AT1 receptor, and promotes the activation of NAD(P)
H oxidase, which leads to an increase in reactive oxygen species (ROS) production ROS
promote subsequent phosphorylation of JAK/STAT and JNK proteins. Regarding
p38MAPK and ERK1/2 proteins, we found that their activation does not involve
NAD(P)H oxidase.Acknowledgments
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